Martin Klabusay
About
In The Last Decade
Martin Klabusay
49 papers receiving 696 citations
Peers
Comparison fields: 5 of 90
- Genetics 339
- Molecular Biology 219
- Surgery 219
- Pathology and Forensic Medicine 116
- Immunology 109
Countries citing papers authored by Martin Klabusay
This map shows the geographic impact of Martin Klabusay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Klabusay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Klabusay more than expected).
Fields of papers citing papers by Martin Klabusay
This network shows the impact of papers produced by Martin Klabusay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Klabusay. The network helps show where Martin Klabusay may publish in the future.
Co-authorship network of co-authors of Martin Klabusay
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Klabusay. A scholar is included among the top collaborators of Martin Klabusay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Klabusay. Martin Klabusay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 8 | |
| 3 | 4 | |
| 4 | 28 | |
| 5 | 16 | |
| 6 | 18 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 37 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 24 | |
| 13 | 10 | |
| 14 | 15 | |
| 15 | 3 | |
| 16 | 78 | |
| 17 | 29 | |
| 18 | [Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation]. | 1 |
| 19 | 1 | |
| 20 | Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.